QPPV.COM KNOWLEDGE ASSESSMENT

CMDh: Role, Functions and Regulatory Significance in the EU Medicines System

Test your understanding of the concepts covered by What Is CMDh? Role, Functions and Regulatory Significance in the EU Medicines System.

Question 1 of 10Pass mark: 80%

Question 1 of 10 During an MRP, a CMS raises a disagreement based on a potential serious risk to public health. What is the normal role of CMDh at the next stage?

To conduct a completely independent centralised authorisation assessment To attempt to reach agreement between the participating Member States To issue an immediate European Commission decision To close the procedure without considering the CMS's reasoning

Question 2 of 10 Which situation best represents a decentralised procedure rather than a mutual recognition procedure?

An authorised product is recognised in additional Member States A product without existing national authorisation is assessed simultaneously by several participating Member States A centrally authorised product undergoes a periodic safety update A national authority implements a European Commission decision

Question 3 of 10 Which statement best reflects the legal status of marketing authorisations produced through MRP or DCP?

They are always a single Union marketing authorisation issued by CMDh They remain national authorisations, although the assessment and regulatory coordination occur across Member States They are temporary authorisations held by EMA until CHMP confirms them They are automatically converted into Commission authorisations after every variation

Question 4 of 10 When interpreting a CMDh safety position, which sequence is most useful for avoiding confusion between scientific assessment and regulatory consequence?

Read the voting outcome first and disregard the legal basis Identify the procedure and products, review the PRAC conclusion, then assess CMDh's position and required implementation measures Assume that the CMDh position is identical to the PRAC recommendation Begin with the communication plan and infer the authorisation status afterward

Question 5 of 10 Which statement best explains why the existence of CMDh does not imply a general European marketing-authorisation authority?

CMDh operates only in the veterinary field Its mandate is tied to coordination of specified national-authorisation procedures and related safety matters, while national authorisations remain under national authorities CMDh has no legal basis in EU legislation Its members are independent of all Member State authorities

Question 6 of 10 In a safety-related procedure involving only nationally authorised medicines, which sequence best reflects the relationship between PRAC and CMDh?

CMDh performs the safety assessment and PRAC adopts the national position PRAC adopts a pharmacovigilance recommendation and CMDh considers it in adopting its position CHMP assesses the safety issue and CMDh replaces the European Commission The European Commission recommends action and PRAC implements it nationally

Question 7 of 10 What is the significance of the phrase 'potential serious risk to public health' in an Article 29 disagreement?

The risk must already have been conclusively proven before it can be raised It is a statutory threshold allowing a Member State to challenge the proposed outcome on a potential serious-risk basis It refers only to a confirmed manufacturing defect It is a non-regulatory term used solely for public communications

Question 8 of 10 Which interpretation of a CMDh majority position is most precise?

It is merely a non-binding scientific discussion with no implementation consequences It records the position reached under the applicable voting rules and may trigger a Commission process leading to a binding Union decision It proves that PRAC and all Member States unanimously agreed It gives CMDh the same legal role as the European Commission

Question 9 of 10 A regulatory professional sees a document describing a PRAC recommendation and a CMDh position for nationally authorised medicines. What is the most appropriate interpretation?

The two documents are redundant because CMDh merely performs administrative translation PRAC supplied the pharmacovigilance assessment, while CMDh considered the recommendation and established the applicable regulatory position CMDh performed the initial safety assessment and PRAC implemented national changes The document necessarily concerns a centrally authorised product

Question 10 of 10 A CMDh safety position is adopted by consensus. Which consequence is most consistent with the article?

The position is implemented by the Member States according to the applicable timetable The position automatically becomes a CHMP opinion The matter must always be sent to the European Commission for a binding decision No national action is possible until PRAC adopts a second recommendation

QPPV.com

CMDh: Role, Functions and Regulatory Significance in the EU Medicines System

Cookie Settings